Effects of Dehydroepiandrosterone on ovary.
Phase 2
- Conditions
- Diseases of the genitourinary system.Female infertilityComplications associated with artificial fertilizationN97N98
- Registration Number
- IRCT2017091529374N1
- Lead Sponsor
- Vice chancellor of Mazandaran University of Medical Science.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 70
Inclusion Criteria
Infertile women aged 20 to 45 years; normal hysterosalpingography; AMH levels < 1.5 ng/ml; antral follicular counts (AFC) < 7 in both ovaries; prior less than three failed in vitro fertilization cycles. Exclusion criteria: Normal ovarian response in ovulatory cycles or in vitro fertilization cycles.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anti-mullerian hormone rate. Timepoint: Before intervention, six weeks after intervention. Method of measurement: Laboratory kits.;Clinical pregnancy rates. Timepoint: Forth weeks after embryo transfer. Method of measurement: Questionnare.
- Secondary Outcome Measures
Name Time Method Miscarriage rates. Timepoint: Till twenty weeks after embryo transfer. Method of measurement: File.;Antral Follicular counts. Timepoint: Before treatment, six weeks after treatments. Method of measurement: ultrasonography.